The US Food and Drug Administration (FDA) has given its first approval to an aceclidine-based eye drop for the treatment of presbyopia in adults. Maker Lenz Therapeutics said it is ready and excite
The International Agency for the Prevention of Blindness (IAPB) is inviting eye health professionals to capture what it means to #LoveYourEyes by entering the IAPB World Sight Day Photo Competition.
The FDA has approved Alcon’s Tryptyr (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for the treatment of signs and symptoms of dry eye disease (DED). A first-in-class, transien
With every blink, the meibomian glands release meibum that contributes to the outermost layer of the tear film. Abnormal blinking can reduce meibum release and may lead to more permanent changes. However, the exact relationship between blinking and meibomian gland dysfunction (MGD) is not well under
Contact lens discomfort (CLD) has been widely recognised as one of the primary factors influencing contact lens (CL) drop out1,2. As noted in my other CL article on this page, CL wear affects various tear film characteristics, with disruption of the pre-lens lipid layer being identified as critical
The lipid layer, the thin outermost layer of the tear film, plays a critical role in preventing tear evaporation and maintaining ocular surface health. Even a thin but stable lipid layer can support tear film homeostasis1, but this requires frequent and complete blinking, a mechanism often compromis
Building on the success of Australia’s Optical Distributors and Manufacturers Association’s (ODMA’s) inaugural Women in Optics event in June 2025, a Facebook group has been launched to keep momentum g
Photobiomodulation (or LLLT) for AMD is now available in New Zealand
Following the release of three-month interim findings1, the Ocular Surface Laboratory (OSL) team has now completed the full six-month analysis of a trial comparing handheld thermal pulsation therapy w
A new study has found therapeutic potential in synthetic collagen mimetic peptides (CMPs) in treating ophthalmic disease, including myopia. Published in Pharmaceuticals, the study results indicate t
A new imaging approach, Fun-IVCM, is able to track the presence of inflammation in dry eye disease
Since dry eye often needs long-term and regular treatment with eye drops, compliance is important to achieve favourable therapeutic outcomes. Difficulty in squeezing eye drop containers has been reported as one of the major barriers for eye drop compliance1,2.
